MVM Partners

Attachments

*Venture Capital Companies: Life Science & Healthcare Investors (Medical Imaging)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations

2020: The round was led by MVM Partners with participation from existing investors MedTech Venture Partners and BlueStone Venture Partners.
AccuVein Secures $22.5 Million Series B Financing through MVM Life Science Partners and Bessemer Venture Partners (2011)
Akhilesh Pathipati Partner MVM Partners (2021)
Also participating were St. Louis-based Ascension Health Ventures, London-based MVM Life Science Partners and New York-based Arc
Fletcher Spaght Ventures, Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures also participated in the round.
Inked a $5 million Series B financing from MVM Life Science Partners and took in new money from its existing angel investors (2011)
Investors: Aweida Venture Partners, Leerink Partners, MVM Life Science Partners, ONSET Ventures, Pitango Venture Capital
Investors: Baxter International, MVM Life Science Partners
MVM Life Science Partners, Claremont Creek Ventures
Participants include Rho Ventures, Alta Partners, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Mitsubishi International and MVM Life Science Partners.
The round was co-led by Novo A/S and SV Life Sciences, and included MVM Life Science Partners, all existing investors in Vantia.